Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin kappa variable 1D-35 (IGKV1D-35) is a human pseudogene mapped to chromosome 2. It belongs to the group of kappa variable genes that contribute to antibody light chain gene diversity; however, this specific segment is not functional and does not produce a protein. As a variable segment pseudogene, it is included in reference gene tables for immunoglobulin genes but is not considered a therapeutic target and does not serve as a biomarker or druggable entity. Functionally, immunoglobulin variable segments are part of the gene cluster that enables antibody diversity through somatic recombination in B cells; however, pseudogenes like IGKV1D-35 have accumulated mutations or deletions and cannot participate in this process.
None, as it does not produce a functional protein
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin kappa variable 1D-35 (pseudogene) (IGKV1D-35).